Condition: MASH · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and activity of RO7790121 in participants with advanced metabolic dysfunction-associated steatohepatitis (MASH) fibrosis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Adobe Clinical Research, LLC | Tucson, Arizona, United States | — |
| Gastrointestinal Specialists of Georgia, PC | Marietta, Georgia, United States | — |
| Delta Research Partners, LLC (Bastrop) | Bastrop, Louisiana, United States | — |
| Jubilee Clinical Research NV, LLC | Las Vegas, Nevada, United States | — |
| Innovative Clinical Research | Clarksville, Tennessee, United States | — |
| Pinnacle Clinical Research - Austin | Austin, Texas, United States | — |
| Bellaire Clinical Research, LLC | Bellaire, Texas, United States | — |
| Pinnacle Clinical Research Georgetown | Georgetown, Texas, United States | — |
| DHR Health Institute for Research and Development | McAllen, Texas, United States | — |
| Pinnacle Clinical Research, PLLC | San Antonio, Texas, United States | — |
| GI Alliance | Southlake, Texas, United States | — |
| Centro de Investigacion y Gastroenterologia | Mexico City, Mexico CITY (federal District), Mexico | — |
+ 3 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.